# Contact Medicine TB-500: Editorial Inquiries About the TB-500 Digest

> Contact Medicine TB-500 for editorial inquiries and corrections about our cited TB-500 and thymosin beta-4 research digest. We do not provide medical advice and we do not sell any product.

Editorial inquiries, source suggestions, and corrections to the TB-500 digest are welcome. Medical questions are not — there is no clinician here to answer them.

## Editorial inquiries and corrections

Use the form below to reach Medicine TB-500 about anything editorial: a study we should cite, a citation that needs fixing, or a factual correction to how a finding on TB-500 or thymosin beta-4 is summarized. We take accuracy seriously, and the fastest way to improve this digest is to point us at a source.

What we cannot answer is anything clinical. We do not provide medical advice, we do not recommend doses, and we do not offer consultations or prescriptions. There is no clinic, pharmacy, or prescriber behind this site, and we do not sell, supply, or source any product. Questions about obtaining TB-500 are outside what this editorial project does and will not be answered.

## What to expect

Messages are read as editorial correspondence. If you have flagged a genuine error or a strong primary source, we would rather update the digest than leave it wrong. Please include a link or citation where you can — a DOI, a PubMed identifier, or an FDA page is far more useful than a general claim, and it lets us verify before we change anything.

This remains a reading project about a research compound, not a service. The most useful thing this site can offer is an honest, cited account of what the TB-500 and thymosin beta-4 literature actually shows — and the boundaries of that account are part of the account. We will not respond to requests for sources of supply, dosing guidance, or clinical advice, because providing them is not what this project is and not something an editorial publisher is equipped to do. Corrections, citations, and questions about how a finding is summarized are exactly what this inbox is for, and they are the fastest route to a more accurate digest.

---

A depth-layered reading of the TB-500 and thymosin beta-4 record — the seven-mer kept distinct from its full-length parent, the human-trial gap surfaced first, and no clinic, vendor, or prescription anywhere in the void.